Current reports
Up-to-date announcements resulting from information obligations of listed companies.
Current reports published before January 1, 2024 are available on the Polish section:
| Report | Details | Publication | Action |
|---|---|---|---|
| ESPI Report 27/2025 |
Information on the conclusion of a significant sales agreement |
17.04.2025 | Read more |
| ESPI Report 26/2025 |
Notification of transactions on the Company's shares |
14.04.2025 | Read more |
| ESPI Report 25/2025 |
Operational highlights of the medical devices, IT solutions and services sales segment |
11.04.2025 | Read more |
| ESPI Report 24/2025 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
10.04.2025 | Read more |
| ESPI Report 23/2025 | Adoption of directional resolution on division of the Company | 27.03.2025 | Read more |
| ESPI Report 22/2025 |
Notification of transactions on the Company's shares |
10.03.2025 | Read more |
| ESPI Report 21/2025 |
Information on the conclusion of a significant sales agreement |
28.02.2025 | Read more |
| ESPI Report 20/2025 |
Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company |
27.02.2025 | Read more |
| ESPI Report 19/2025 |
Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company |
27.02.2025 | Read more |
| ESPI Report 18/2025 |
Notification of transactions executed by a person discharging managerial responsibilities |
21.02.2025 | Read more |
| ESPI Report 17/2025 with correction |
Notification of transactions executed by a person discharging managerial responsibilities |
21.02.2025 | Read more |
| ESPI Report 16/2025 |
Information on the completion of the book-building process for Synektik SA shares |
19.02.2025 | Read more |
| ESPI Report 15/2025 |
Information on the commencement of the book-building process for Synektik SA shares |
19.02.2025 | Read more |
| ESPI Report 14/2025 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
18.02.2025 | Read more |
| ESPI Report 13/2025 |
Estimated revenue in Q1/ FY 2024 |
24.01.2025 | Read more |
| ESPI Report 12/2025 |
List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 22 January 2025 |
23.01.2025 | Read more |
| ESPI Report 11/2025 |
Constitution of the Company’s Supervisory Board |
22.01.2025 | Read more |
| ESPI Report 10/2025 |
Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 22 January 2025 |
22.01.2025 | Read more |
| ESPI Report 9/2025 |
Appointment of Supervisory Board Members |
22.01.2025 | Read more |
| ESPI Report 8/2025 |
Dividend payout resolution |
22.01.2025 | Read more |
| ESPI Report 7/2025 |
Additional documentation for the Ordinary Shareholder Meeting of SYNEKTIK SA |
20.01.2025 | Read more |
| ESPI Report 6/2025 |
Declaration on not exercising the personal right to appoint Supervisory Board members |
20.01.2025 | Read more |
| ESPI Report 5/2025 |
Submission of candidates to the Issuer’s Supervisory Board |
16.01.2025 | Read more |
| ESPI Report 4/2025 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
15.01.2025 | Read more |
| ESPI Report 3/2025 |
Acquisition of shares in a company holding medical IT software |
14.01.2025 | Read more |
| ESPI Report 2/2025 |
Operational highlights of the medical devices, IT solutions and services sales segment |
13.01.2025 | Read more |
| ESPI Report 1/2025 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
09.01.2025 | Read more |
| ESPI Report 66/2024 |
Notification of transactions on the Company's shares |
30.12.2024 | Read more |
| ESPI Report 65/2024 |
Announcement on Convening the Ordinary Shareholder Meeting to be held on 22 January 2025 |
23.12.2024 | Read more |
| ESPI Report 64/2024 |
Management Board’s recommendation to pay a dividend for the 2023 financial year |
23.12.2024 | Read more |
| ESPI Report 63/2024 |
Appointment of the Management Board Members for another term of office |
19.12.2024 | Read more |
| ESPI Report 62/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
18.12.2024 | Read more |
| ESPI Report 61/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
17.12.2024 | Read more |
| ESPI Report 60/2024 |
Modification of the date of publication of the standalone financial statements and the consolidated financial statements for the 2023 financial year |
17.12.2024 | Read more |
| ESPI Report 59/2024 |
Selection of a Member to the Supervisory Board’s Nomination and Compensation Committee |
26.11.2024 | Read more |
| ESPI Report 58/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
08.11.2024 | Read more |
| ESPI Report 57/2024 |
Information on the conclusion of a significant agreement |
07.11.2024 | Read more |
| ESPI Report 56/2024 |
Information on the conclusion of a significant sales agreement |
05.11.2024 | Read more |
| ESPI Report 55/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
04.11.2024 | Read more |
| ESPI Report 54/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
28.10.2024 | Read more |
| ESPI Report 53/2024 |
Information on the conclusion of a significant agreement |
24.10.2024 | Read more |
| ESPI Report 52/2024 |
Dates of publication of periodic reports |
18.10.2024 | Read more |
| ESPI Report 51/2024 |
Filling the vacancy on the Audit Committee and election of the Audit Committee Chairman |
16.10.2024 | Read more |
| ESPI Report 50/2024 |
Operational highlights of the medical devices, IT solutions and services sales segment |
11.10.2024 | Read more |
| ESPI Report 49/2024 |
Extension of the distribution agreement with Intuitive Surgical |
10.10.2024 | Read more |
| ESPI Report 48/2024 |
Information on the conclusion of a significant sales agreement |
09.10.2024 | Read more |
| ESPI Report 47/2024 |
List of shareholders with at least 5% of the total number of votes at the Extraordinary Shareholder Meeting held on 8 October 2024 |
09.10.2024 | Read more |
| ESPI Report 46/2024 |
Text of the resolutions adopted at the Extraordinary Shareholder Meeting of Synektik SA on 8 October 2024 |
08.10.2024 | Read more |
| ESPI Report 45/2024 |
Appointment of a Supervisory Board member |
08.10.2024 | Read more |
| ESPI Report 44/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
08.10.2024 | Read more |
| ESPI Report 43/2024 |
Proposing a candidate to the Issuer’s Supervisory Board |
07.10.2024 | Read more |
| ESPI Report 42/2024 |
Information on the conclusion of a significant agreement |
03.10.2024 | Read more |
| ESPI Report 41/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
25.09.2024 | Read more |
| ESPI Report 40/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
24.09.2024 | Read more |
| ESPI Report 39/2024 |
Announcement on Convening an Extraordinary Shareholder Meeting to be held on 8 October 2024 |
10.09.2024 | Read more |
| ESPI Report 38/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
06.09.2024 | Read more |
| ESPI Report 37/2024 |
Resignation of a Synektik SA Supervisory Board Member |
02.09.2024 | Read more |
| ESPI Report 36/2024 |
Information on the conclusion of a significant sales agreement |
22.08.2024 | Read more |
| ESPI Report 35/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
20.08.2024 | Read more |
| ESPI Report 34/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
14.08.2024 | Read more |
| ESPI Report 33/2024 |
Annex to the distribution agreement with Intuitive Surgical Sarl |
01.08.2024 | Read more |
| ESPI Report 32/2024 |
Information on the conclusion of a significant agreement |
26.07.2024 | Read more |
| ESPI Report 31/2024 |
Operational highlights of the medical devices, IT solutions and services sales segment |
08.07.2024 | Read more |
| ESPI Report 30/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
13.06.2024 | Read more |
| ESPI Report 29/2024 |
Information on the conclusion of a significant sales agreement |
03.06.2024 | Read more |
| ESPI Report 28/2024 |
Information on the conclusion of a significant agreement |
24.05.2024 | Read more |
| ESPI Report 27/2024 |
Partnership agreement for exclusive distribution of Symani microsurgery robots |
22.05.2024 | Read more |
| ESPI Report 26/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
17.05.2024 | Read more |
| ESPI Report 25/2024 |
Information on the conclusion of a significant agreement |
06.05.2024 | Read more |
| ESPI Report 24/2024 |
Contract for the exclusive distribution of Qure.ai’s global artificial intelligence solution to assess the results of radiology tests in Poland, the Czech Republic and Slovakia |
19.04.2024 | Read more |
| ESPI Report 23/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
18.04.2024 | Read more |
| ESPI Report 22/2024 |
Operational highlights of the medical devices, IT solutions and services sales segment |
10.04.2024 | Read more |
| ESPI Report 21/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
09.04.2024 | Read more |
| ESPI Report 20/2024 |
Information on the conclusion of a significant sales agreement |
28.03.2024 | Read more |
| ESPI Report 19/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
12.03.2024 | Read more |
| ESPI Report 18/2024 |
Information on the conclusion of a significant sales agreement |
08.03.2024 | Read more |
| ESPI Report 17/2024 |
List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 26 February 2024 |
27.02.2024 | Read more |
| ESPI Report 16/2024 |
Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 26 February 2024 |
27.02.2024 | Read more |
| ESPI Report 15/2024 |
Dividend payout resolution |
26.02.2024 | Read more |
| ESPI Report 14/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
26.02.2024 | Read more |
| ESPI Report 13/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
23.02.2024 | Read more |
| ESPI Report 12/2024 |
Information on the conclusion of a significant sales agreement |
22.02.2024 | Read more |
| ESPI Report 11/2024 |
Expansion of a cooperation agreement |
22.02.2024 | Read more |
| ESPI Report 10/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
21.02.2024 | Read more |
| ESPI Report 9/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
19.02.2024 | Read more |
| ESPI Report 8/2024 |
Estimated revenue in Q1 2023 |
31.01.2024 | Read more |
| ESPI Report 7/2024 |
Obtaining a patent for a cardiac marker in Japan |
25.01.2024 | Read more |
| Appendix 2 – ESPI Report 6/2024 |
Auditor's assessment of Synektik's report on payments of the Management Board and Supervisory Board for FY2022 |
25.01.2024 | Read more |
| Appendix 1 – ESPI Report 6/2024 |
Report on payments of the Management Board and Supervisory Board for FY2022 |
25.01.2024 | Read more |
| ESPI Report 6/2024 |
Completion of documentation to be discussed at the Ordinary General Meeting of SYNEKTIK SA |
25.01.2024 | Read more |
| Appendix – ESPI Report 5/2024/K |
Corrected draft resolutions attached to ESPI report 5/2024/K |
22.01.2024 | Read more |
| ESPI Report 5/2024/K |
Correction of current report ESPI 5/2024 - Announcement on convening the Ordinary General Meeting of Shareholders for February 26, 2024 |
22.01.2024 | Read more |
| Appendixes – ESPI Report 5/2024 | 22.01.2024 | Read more | |
| ESPI Report 5/2024 |
Announcement on the convening of the Ordinary General Meeting of Shareholders for February 26, 2024 |
22.01.2024 | Read more |
| ESPI Report 4/2024 |
Recommendation of the Management Board on the payment of dividends for FY2022 |
19.01.2024 | Read more |
| ESPI Report 3/2024 |
Establishment of a bank guarantee for a counterparty |
17.01.2024 | Read more |
| ESPI Report 2/2024 |
Update on the cardiotracer project |
10.01.2024 | Read more |
| ESPI Report 1/2024 |
Selected operating data of the medical devices, IT solutions and services sales segment |
08.01.2024 | Read more |